|
Vaccine Detail
rSPV-HA1 (Swine influenza virus H1N1) |
Vaccine Information |
- Vaccine Name: rSPV-HA1 (Swine influenza virus H1N1)
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004636
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- Vector:
- Preparation: Recombinant swinepox virus (rSPV-HA1) expressing hemagglutinin (HA1) of H1N1 SIV (Xu et al., 2012).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Pig Response
- Vaccination Protocol: At 5 weeks of age, groups 1 and 2 were individually inoculated intramuscularly in the neck area with rSPV-HA1 or wtSPV at 1 × 10^7.0 TCID50 in 1 ml EMEM per pig. Group 3 was inoculated with 1 ml EMEM (Xu et al., 2012).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: All pigs were challenged with 2 × 10^5.0 TCID50 H1N1 SIV per pig by nasal inoculation (Xu et al., 2012).
- Efficacy: Complete protection of pigs against H1N1 SIV challenge was observed. No pigs showed evident systemic and local reactions to the vaccine and no SIV shedding was detected from pigs vaccinated with rSPV-HA1 after challenge (Xu et al., 2012).
|
References |
Xu et al., 2012: Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs. Vaccine. 2012; 30(20); 3119-3125. [PubMed: 22391400].
|
|